Matches in Wikidata for { <http://www.wikidata.org/entity/Q83223892> ?p ?o ?g. }
Showing items 1 to 67 of
67
with 100 items per page.
- Q83223892 description "article scientifique publié en 2006" @default.
- Q83223892 description "artículu científicu espublizáu en mayu de 2006" @default.
- Q83223892 description "im Mai 2006 veröffentlichter wissenschaftlicher Artikel" @default.
- Q83223892 description "scientific article published on 01 May 2006" @default.
- Q83223892 description "wetenschappelijk artikel" @default.
- Q83223892 description "наукова стаття, опублікована в травні 2006" @default.
- Q83223892 name "The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial" @default.
- Q83223892 name "The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial" @default.
- Q83223892 type Item @default.
- Q83223892 label "The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial" @default.
- Q83223892 label "The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial" @default.
- Q83223892 prefLabel "The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial" @default.
- Q83223892 prefLabel "The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial" @default.
- Q83223892 P1433 Q83223892-57C14431-473F-419D-8CA6-AEACF227E3CE @default.
- Q83223892 P1476 Q83223892-1A128F67-AEA8-43F3-9560-12A63F301B24 @default.
- Q83223892 P2093 Q83223892-34CFC321-E517-43B4-9766-FA242E155B12 @default.
- Q83223892 P2093 Q83223892-41512F0D-8371-4CA4-A9E6-E0FD78C15EEF @default.
- Q83223892 P2093 Q83223892-4B2EAE19-CA99-440F-B1B1-09577F1E1572 @default.
- Q83223892 P2093 Q83223892-4E979134-87EC-46DF-A777-E0D0188E3985 @default.
- Q83223892 P2093 Q83223892-5B537AB9-DC94-4919-A71A-23BA14A81563 @default.
- Q83223892 P2093 Q83223892-8AF9A975-FD32-41C2-92EE-49142035463F @default.
- Q83223892 P2093 Q83223892-BAEBDFBE-C502-4EF6-B1B4-9AC9A0DBC35C @default.
- Q83223892 P2093 Q83223892-D5663463-EF6D-461F-9296-DD4018068F26 @default.
- Q83223892 P2093 Q83223892-E1EA36C9-41E6-471E-A864-2B8BD0DB5924 @default.
- Q83223892 P2093 Q83223892-E1FC5434-4A45-49BE-941D-9D8DE4818FE1 @default.
- Q83223892 P2093 Q83223892-ECC55D46-B0E4-495C-89F3-18BFF3BAB464 @default.
- Q83223892 P304 Q83223892-A08E6CB1-28B7-4AB4-AD52-A63BBF6E2A84 @default.
- Q83223892 P31 Q83223892-BF431CF6-9EE6-4038-AAC3-A8251774681A @default.
- Q83223892 P356 Q83223892-2CDC40AB-C97C-4A3C-8773-851ED88882B7 @default.
- Q83223892 P433 Q83223892-05216B4C-EBDA-412E-AC22-764724EFAC56 @default.
- Q83223892 P478 Q83223892-CBF0813B-7E4C-4718-8F99-28741442DCFF @default.
- Q83223892 P50 Q83223892-524617AE-5BA3-4D9A-9B99-7B048E9809DF @default.
- Q83223892 P50 Q83223892-6DD8C71D-0D14-44B7-A62C-BD98D3A895FA @default.
- Q83223892 P577 Q83223892-EA944DF6-8C2E-4B68-9EE2-7BD47EE5C229 @default.
- Q83223892 P698 Q83223892-64BFC20A-1308-4842-86B0-2CF9E32D7623 @default.
- Q83223892 P921 Q83223892-3B018E18-3B4A-4B86-96FE-B38804647D78 @default.
- Q83223892 P921 Q83223892-3D59AB79-0A18-463F-A05B-E9956C8DC0A6 @default.
- Q83223892 P921 Q83223892-4D17F505-3CF6-40CE-909E-FDA66683F5A7 @default.
- Q83223892 P921 Q83223892-AD2210B6-0DF2-4261-8E4D-D7F8DBD58E54 @default.
- Q83223892 P356 ART.21778 @default.
- Q83223892 P698 16649186 @default.
- Q83223892 P1433 Q23929027 @default.
- Q83223892 P1476 "The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial" @default.
- Q83223892 P2093 "Anna Filipowicz-Sosnowska" @default.
- Q83223892 P2093 "Artur J Racewicz" @default.
- Q83223892 P2093 "DANCER Study Group" @default.
- Q83223892 P2093 "Eva W Hessey" @default.
- Q83223892 P2093 "Joy Schechtman" @default.
- Q83223892 P2093 "Leszek Szczepanski" @default.
- Q83223892 P2093 "Nicole F Li" @default.
- Q83223892 P2093 "Ronald F van Vollenhoven" @default.
- Q83223892 P2093 "Roy Fleischmann" @default.
- Q83223892 P2093 "Sunil Agarwal" @default.
- Q83223892 P2093 "Timothy M Shaw" @default.
- Q83223892 P304 "1390-1400" @default.
- Q83223892 P31 Q13442814 @default.
- Q83223892 P356 "10.1002/ART.21778" @default.
- Q83223892 P433 "5" @default.
- Q83223892 P478 "54" @default.
- Q83223892 P50 Q19859634 @default.
- Q83223892 P50 Q93106996 @default.
- Q83223892 P577 "2006-05-01T00:00:00Z" @default.
- Q83223892 P698 "16649186" @default.
- Q83223892 P921 Q187255 @default.
- Q83223892 P921 Q269829 @default.
- Q83223892 P921 Q412323 @default.
- Q83223892 P921 Q422232 @default.